To view this email as a web page, click here.

Chemo Brain in Cancer Patients: What Is It and How Can It Be Managed?

Many patients complain of “chemo brain,” or a drop in cognitive function during or after receiving chemotherapy, but there are strategies to manage chemo brain, as well as research on how chemotherapy affects the brain long-term.

Combination Immunotherapy Efficacy in Lung Cancer May Differ by Patient Sex

A study in the Journal of the National Cancer Institute evaluated responses in men vs women to combination chemotherapy and a PD-1 or PD-L1 inhibitor.

IN CASE YOU MISSED IT

CX-01 Heparin Derivative Investigated for Older Patients With AML

A randomized phase II trial investigated whether adding CX-01, a low anticoagulant heparin derivative, to standard care improves outcomes in older patients with acute myeloid leukemia.

Read more

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.